Source:http://linkedlifedata.com/resource/pubmed/id/20144041
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-3-1
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1557-9077
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
341-2
|
pubmed:meshHeading |
pubmed-meshheading:20144041-Aged,
pubmed-meshheading:20144041-Chemokine CXCL10,
pubmed-meshheading:20144041-Disease-Free Survival,
pubmed-meshheading:20144041-Female,
pubmed-meshheading:20144041-Graves Disease,
pubmed-meshheading:20144041-Humans,
pubmed-meshheading:20144041-Male,
pubmed-meshheading:20144041-Middle Aged
|
pubmed:year |
2010
|
pubmed:articleTitle |
Serum chemokine (C-X-C motif ) ligand 10 levels are elevated in patients with Graves' disease in long-term remission.
|
pubmed:publicationType |
Letter
|